Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)

Rhea-AI Summary

Definitive Healthcare (Nasdaq: DH) has announced the granting of inducement awards to its newly hired senior leader. The company's Human Capital Management and Compensation Committee approved inducement awards for Jeff Moyer, who joins as SVP of Growth and Sales Operations.

The awards include 364,432 time-based restricted stock units (RSUs), effective April 3, 2025. The RSUs will vest according to the following schedule: 25% on April 1, 2026, with the remaining amount vesting in quarterly installments of 6.25% over the subsequent three years. These awards were granted under Definitive Healthcare's 2023 Inducement Plan and comply with Nasdaq Listing Rule 5635(c)(4).

Positive

• Strategic hire of SVP of Growth and Sales Operations indicates focus on business expansion
• Structured vesting schedule helps retain key talent over 4-year period

Negative

• Potential dilution of shareholders due to issuance of 364,432 new RSUs

News Market Reaction

+0.20%

1 alert

+0.20% News Effect

On the day this news was published, DH gained 0.20%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

FRAMINGHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of one senior leader, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare’s Board of Directors granted inducement awards. The Committee granted Jeff Moyer, Definitive Healthcare’s new SVP of Growth and Sales Operations, an inducement award consisting of 364,432 time-based restricted stock units (“RSUs”), effective April 3, 2025. These awards were individually negotiated and granted as an inducement material to Mr. Moyer’s respective commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).

Each of the awards is subject to the terms and conditions of Definitive Healthcare’s 2023 Inducement Plan (the “Plan”) and the terms and conditions of an applicable award agreement covering the grant.

Mr. Moyer’s RSUs will vest as follows, subject to Mr. Moyer’s continued employment through each such date: (i) 25% will vest on April 1, 2026; (ii) the remainder will vest in quarterly installments equal to 6.25% of the total RSUs over the subsequent 3 years, until fully vested.

About Definitive Healthcare

At Definitive Healthcare, our passion is to transform data, analytics, and expertise into healthcare commercial intelligence. We help clients uncover the right markets, opportunities, and people, so they can shape tomorrow’s healthcare industry. Our SaaS platform creates new paths to commercial success in the healthcare market, so companies can identify where to go next. Learn more at definitivehc.com.

Investor Contact:
Brian Denyeau
ICR for Definitive Healthcare
brian.denyeau@icrinc.com
646-277-1251

Media Contact:
Bethany Swackhamer
bswackhamer@definitivehc.com

FAQ

How many RSUs were granted to Jeff Moyer in Definitive Healthcare's (DH) inducement award?

Jeff Moyer was granted 364,432 time-based restricted stock units (RSUs) as part of his inducement award at Definitive Healthcare.

What is the vesting schedule for DH's new SVP of Growth and Sales Operations' RSUs?

The RSUs vest 25% on April 1, 2026, with the remaining 75% vesting in quarterly installments of 6.25% over the following 3 years.

When will Jeff Moyer's RSUs begin vesting at Definitive Healthcare (DH)?

The first vesting date for Jeff Moyer's RSUs is scheduled for April 1, 2026, when 25% of the units will vest.

Under which plan were DH's inducement awards granted in April 2025?

The inducement awards were granted under Definitive Healthcare's 2023 Inducement Plan in accordance with Nasdaq Listing Rule 5635(c)(4).